Skip to content
Screener

AngioDynamics ANGO Q3 2025 earnings

Reported April 2, 2025 · Before market open

Revenue$72.0MMiss by $2.3M
EPS$0.03Beat by $0.16
Revenue estimate$74.3M
EPS estimate-$0.13

Next report

Oct 8, 2026 (In 5 days)
Revenue estimate$80.5M
EPS estimate-$0.11

Financials

Q3 2025

Income statement

See full
Revenue$72.0M-4.2%
Gross profit$38.9M+8.4%
Operating income-$10.0M+95.0%
Net income-$4.4M+97.7%
EPS (diluted)-$0.11+97.6%

Balance sheet

See full
Cash & equivalents$44.8M-42.9%
Total debt$7.2M+80.8%
Total equity$185.9M-15.0%
Total assets$285.4M-12.1%

Cash flow

See full
Operating cash flow-$13.2M-5.1%
CapEx$1.8M+196%
Free cash flow-$15.0M-13.9%

Valuation & ratios

Valuation

as of 02/28/25
See full
Market cap$375.93M+71.8%
Enterprise value$338.34M+134%
P/S1.3×+0.7×

Profitability

See full
Gross margin54.4%+4.2pp
Operating margin-17.2%-7.2pp
Net margin-14.6%-6.3pp

Returns & leverage

See full
Return on equity-20.5%-8.2pp
Debt / equity0×0.0×
Current ratio2.2×-0.1×

Segments

By product

See full
Med Device$40.7M-17.6%
Med Tech$31.3M+21.3%

By geography

See full
United States$61.3M—

FAQ

When did AngioDynamics report Q3 2025 earnings?
AngioDynamics (ANGO) reported Q3 2025 earnings on April 2, 2025 before market open.
What were AngioDynamics's Q3 2025 revenue and EPS?
AngioDynamics reported revenue of $72.0M and eps of $0.03 for Q3 2025.
Did AngioDynamics beat estimates in Q3 2025?
Revenue missed the consensus estimate of $74.3M by $2.3M. EPS beat the consensus estimate of $-0.13 by $0.16.
Where can I find AngioDynamics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001140361-25-011779) and the 10-Q periodic report (0001275187-25-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.